medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2022, Number 3

<< Back Next >>

Cir Card Mex 2022; 7 (3)

Transcatheter edge-to-edge mitral valve repair: A clip around the TEER!

García-Villarreal OA

Language: English
References: 36
Page: 43-45
PDF size: 164.77 Kb.


ABSTRACT

The JAMA Cardiology journal has just released the article by Young et al. regarding the trends in the US among Medicare patients, relating to the issue of mitral valve (MV) repair, whether by the transcatheter or surgical technique. However, given the shortcomings of the transcatheter edge-to-edge MV repair (TEER) technique, both the medical community and the general public require greater information on this procedure in context, when disseminating this type of content without specifying the relevant limitations. TEER as a treatment for mitral regurgitation, has emerged as one of the most impactful cutting-edge technologies in structural interventional cardiology in recent years. However, of particular importance are the main differences between percutaneous and surgical techniques, a pivotal one being the absence of a prosthetic annuloplasty ring in the former option, thus rendering the TEER procedure just partially effective.


REFERENCES

  1. Young MN, Kearing S, Albaghdadi MA, Latib A, Iribarne A. Trends in Transcathetervs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012to 2019. JAMA Cardiol. Published online May 04, 2022. doi:10.1001/jamacardio. 2022.0775.

  2. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for theManagement of Patients with Valvular Heart Disease: Executive Summary: AReport of the American College of Cardiology/American Heart Association JointCommittee on Clinical Practice Guidelines Circulation. 2021;143(5):e35-e71.

  3. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for themanagement of valvular heart disease. Eur Heart J. 2022;43(7):561-632.

  4. Carpentier A. La valvuloplastie reconstructive. Une nouvelle technique de valvuloplastiemitrale [Reconstructive valvuloplasty. A new technique of mitral valvuloplasty].Presse Med. 1969;77(7):251-253.

  5. Carpentier A, Deloche A, Dauptain J, et al. A new reconstructive operation forcorrection of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg.1971;61(1):1-13.

  6. Carpentier A, Relland J, Deloche A, et al. Conservative management of the prolapsedmitral valve. Ann Thorac Surg. 1978;26(4):294-302.

  7. Carpentier A, Chauvaud S, Fabiani JN, et al. Reconstructive surgery of mitral valveincompetence: ten-year appraisal. J Thorac Cardiovasc Surg. 1980;79(3):338-348.

  8. Carpentier A. Cardiac valve surgery--the "French correction". J Thorac CardiovascSurg. 1983;86(3):323-337.

  9. Carpentier A, Adams D, Filsoufi F (Eds) (2010). Carpentier's ReconstructiveValve Surgery. From Valve Analysis to Valve Reconstruction. 1st Edition. EditorialSaunders (W.B.) Co Ltd. Elsevier. ISBN 9780721691688.

  10. Alfieri O, De Bonis M, La Canna G. (Eds.). (2015). Edge-to-Edge Mitral Repair.From a surgical to a percutaneous approach. Springer International PublishingSwitzerland 2015. Electronic version. ISBN978-3-319-19893-4 (eBook).

  11. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repairfor degenerative disease. J Thorac Cardiovasc Surg. 1998;116(5):734-743.

  12. Gillinov AM, Cosgrove DM. Mitral valve repair for degenerative disease. J HeartValve Dis. 2002;11 Suppl 1:S15-S20.

  13. David TE, Armstrong S, McCrindle BW, Manlhiot C. Late outcomes of mitralvalve repair for mitral regurgitation due to degenerative disease. Circulation.2013;127(14):1485-1492.

  14. David TE. Durability of mitral valve repair for mitral regurgitation due to degenerativemitral valve disease. Ann Cardiothorac Surg. 2015;4(5):417-421.

  15. Suri RM, Clavel MA, Schaff HV, et al. Effect of Recurrent Mitral RegurgitationFollowing Degenerative Mitral Valve Repair: Long-Term Analysis of CompetingOutcomes. J Am Coll Cardiol. 2016;67(5):488-498.

  16. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, La CannaG. The double-orifice technique in mitral valve repair: a simple solution for complexproblems. J Thorac Cardiovasc Surg. 2001;122:674-681.

  17. De Bonis M, Lapenna E, Taramasso M, et L. Very long-term durability of theedge-to-edge repair for isolated anterior mitral leaflet prolapse: up to 21 years ofclinical and echocardiographic results. J Thorac Cardiovasc Surg. 2014;148:2027-2032.

  18. De Bonis M, Lapenna E, Maisano F, et al. Long-term results (≤18 years) of theedge-to-edge mitral valve repair without annuloplasty in degenerative mitral regurgitation:implications for the percutaneous approach. Circulation. 2014;130(11Suppl 1):S19-24.

  19. De Bonis M, Lapenna E, Pozzoli A, Giacomini A, Alfieri O. Edge-to-edge surgicalmitral valve repair in the era of MitraClip: what if the annuloplasty ring is missed?Curr Opin Cardiol 2015;30:155-160.

  20. Del Forno B, Castiglioni A, Sala A, et al. Mitral valve annuloplasty. MultimedMan Cardiothorac Surg. 2017.doi: 10.1510/mmcts.2017.016.

  21. Stone GW, Adams DH, Abraham WT, Kappetein AP, Généreux P, Vranckx P,Mehran R, Kuck KH, Leon MB, Piazza N, Head SJ, Filippatos G, Vahanian AS;Mitral Valve Academic Research Consortium (MVARC). Clinical Trial DesignPrinciples and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement:Part 2: Endpoint Definitions: A Consensus Document from the MitralValve Academic Research Consortium. J Am Coll Cardiol. 2015 Jul 21;66(3):308-321. doi: 10.1016/j.jacc.2015.05.049.

  22. De Bonis M, Lapenna E, Lorusso R, Buzzatti N, Gelsomino S, Taramasso M,Vizzardi E, Alfieri O. Very long-term results (up to 17 years) with the double-orificemitral valve repair combined with ring annuloplasty for degenerative mitralregurgitation. J Thorac Cardiovasc Surg. 2012;144(5):1019-24.

  23. Suri RM, Clavel MA, Schaff HV, Michelena HI, Huebner M, Nishimura RA,ET AL. Effect of Recurrent Mitral Regurgitation Following Degenerative MitralValve Repair: Long-Term Analysis of Competing Outcomes. J Am Coll Cardiol.2016 Feb 9;67(5):488-498. doi: 10.1016/j.jacc.2015.10.098.

  24. Gardner MA, Hossack KF, Smith IR. Long-Term Results Following Repair forDegenerative Mitral Regurgitation - Analysis of Factors Influencing Durability.Heart Lung Circ. 2019;28(12):1852-1865. doi: 10.1016/j.hlc.2018.10.011.

  25. Adamo M, Grasso C, Capodanno D, Rubbio AP, Scandura S, Giannini C, et al.Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair:Insights from the multicenter GRASP-IT registry. Am Heart J. 2019;217:32-41.

  26. Buzzatti N, Denti P, Scarfò IS, Giambuzzi I, Schiavi D, Ruggeri S, et al. Midtermoutcomes (up to 5 years) of percutaneous edge-to-edge mitral repair in thereal-world according to regurgitation mechanism: A single-center experience.Catheter Cardiovasc Interv. 2019;94:427-435.

  27. Buzzatti N, De Bonis M, Denti P, Barili F, Schiavi D, Di Giannuario G, et al. Whatis a "good" result after transcatheter mitral repair? Impact of 2+ residual mitralregurgitation. J Thorac Cardiovasc Surg. 2016;151:88-96.

  28. Reichart D, Kalbacher D, Rübsamen N, Tigges E, Thomas C, Schirmer J, et al.The impact of residual mitral regurgitation after MitraClip therapy in functionalmitral regurgitation. Eur J Heart Fail. 2020;22:1840-1848.

  29. García-Villarreal OA. Annuloplasty ring as a sine qua non condition in mitralvalve repair renders transcatheter edge-to-edge repair an imperfect technique totreat mitral valve regurgitation. Cir Card Mex (2022). In press.

  30. Adamo M, Metra M, Alfieri O. Percutaneous valve repair of functional mitralregurgitation: aiming at optimal and durable results. Eur J Heart Fail.2020;22(10):1849-1851. doi: 10.1002/ejhf.1850.

  31. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al; COAPTInvestigators. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. NEngl J Med. 2018;379:2307-2318.

  32. Mack M, Carroll JD, Thourani V, Vemulapalli S, Squiers J, Manandhar P, DeebGM, Batchelor W, Herrmann HC, Cohen DJ, Hanzel G, Gleason T, Kirtane A,Desai N, Guibone K, Hardy K, Michaels J, DiMaio JM, Christensen B, FitzgeraldS, Krohn C, Brindis RG, Masoudi F, Bavaria J. Transcatheter Mitral Valve Therapyin the United States: A Report from the STS/ACC TVT Registry. Ann ThoracSurg. 2022;113(1):337-365. doi: 10.1016/j.athoracsur.2021.07.030.

  33. Kaneko T, Newel PC, Nisivaco S, Yoo SGK, Hirji SA, Hou H, et al. Incidence,Characteristics, and Outcomes of Reintervention After Mitral Transcatheter Edge-To-Edge Repair. J Thorac Cardiovasc Surg (2022). Published: April 12, 2022.DOI:https://doi.org/10.1016/j.jtcvs.2022.02.060.

  34. Kaneko T, Hirji S, Zaid S, Lange R, Kempfert J, Conradi L, et al; CUTTING-EDGEInvestigators. Mitral Valve Surgery After Transcatheter Edge-to-Edge Repair:Mid-Term Outcomes from the CUTTING-EDGE International Registry. JACCCardiovasc Interv. 2021;14:2010-2021.

  35. Chikwe J, O'Gara P, Fremes S, Sundt TM 3rd, Habib RH, Gammie J, et al. MitralSurgery After Transcatheter Edge-to-Edge Repair: Society of Thoracic SurgeonsDatabase Analysis. J Am Coll Cardiol. 2021;78:1-9.

  36. García-Villarreal OA. Transcatheter Edge-to-Edge Mitral Valve Repair in FunctionalMitral Regurgitation. Does it Pass Muster? Still Leaving Plenty to Be Desired.Braz J Cardiovasc Surg. 2022;37(2):I-IV. doi: 10.21470/1678-9741-2022-0129.




2020     |     www.medigraphic.com

    Este sitio utiliza cookies   Estoy de acuerdo